Abstract

Cancer-associated fibroblasts (CAFs) have emerged as a dominant non-hematopoietic cell population in the tumour microenvironment, serving diverse functions in tumour progression. However, the mechanisms via which CAFs influence the anti-tumour immunity remain poorly understood. Here, using multiple tumour models and biopsies from cancer patients, we report that α-SMA+ CAFs can form immunological synapses with Foxp3+ regulatory T cells (Tregs) in tumours. Notably, α-SMA+ CAFs can phagocytose and process tumour antigens and exhibit a tolerogenic phenotype which instructs movement arrest, activation and proliferation in Tregs in an antigen-specific manner. Moreover, α-SMA+ CAFs display double-membrane structures resembling autophagosomes in their cytoplasm. Single-cell transcriptomic data showed an enrichment in autophagy and antigen processing/presentation pathways in α-SMA-expressing CAF clusters. Conditional knockout of Atg5 in α-SMA+ CAFs promoted inflammatory re-programming in CAFs, reduced Treg cell infiltration and attenuated tumour development. Overall, our findings reveal an immunosuppressive mechanism entailing the formation of synapses between α-SMA+ CAFs and Tregs in an autophagy-dependent manner.

Cancer-associated fibroblasts (CAFs) are a predominant stromal cell population in the tumour microenvironment. Here, the authors demonstrate that αSMA + CAFs can form an immunological synapse with regulatory T cells (Tregs) in tumours, which results in Treg activation and expansion in a process that is antigen- and autophagy-dependent.

Details

Title
Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
Author
Varveri, Athina 1 ; Papadopoulou, Miranta 1 ; Papadovasilakis, Zacharias 2 ; Compeer, Ewoud B. 3   VIAFID ORCID Logo  ; Legaki, Aigli-Ioanna 4 ; Delis, Anastasios 5 ; Damaskou, Vasileia 6 ; Boon, Louis 7 ; Papadogiorgaki, Sevasti 8 ; Samiotaki, Martina 9 ; Foukas, Periklis G. 6 ; Eliopoulos, Aristides G. 10   VIAFID ORCID Logo  ; Hatzioannou, Aikaterini 11 ; Alissafi, Themis 12   VIAFID ORCID Logo  ; Dustin, Michael L. 3   VIAFID ORCID Logo  ; Verginis, Panayotis 13   VIAFID ORCID Logo 

 Biomedical Research Foundation Academy of Athens, Center of Clinical, Experimental Surgery & Translational Research, Athens, Greece (GRID:grid.417975.9) (ISNI:0000 0004 0620 8857); University of Crete, Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437) 
 University of Crete, Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437); Foundation for Research and Technology, Institute of Molecular Biology and Biotechnology, Heraklion, Greece (GRID:grid.4834.b) (ISNI:0000 0004 0635 685X) 
 University of Oxford, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 Biomedical Research Foundation Academy of Athens, Center of Clinical, Experimental Surgery & Translational Research, Athens, Greece (GRID:grid.417975.9) (ISNI:0000 0004 0620 8857) 
 Biomedical Research Foundation Academy of Athens, Center of Basic Research, Athens, Greece (GRID:grid.417975.9) (ISNI:0000 0004 0620 8857) 
 Attikon University Hospital, 2nd Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece (GRID:grid.5216.0) (ISNI:0000 0001 2155 0800) 
 JJP Biologics, Warsaw, Poland (GRID:grid.5216.0) 
 University of Crete, Electron Microscopy Laboratory, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437) 
 Biomedical Sciences Research Centre Alexander Fleming, Institute for Bioinnovation, Athens, Greece (GRID:grid.424165.0) (ISNI:0000 0004 0635 706X) 
10  Medical School National and Kapodistrian University of Athens, Laboratory of Biology, School of Medicine, Athens, Greece (GRID:grid.5216.0) (ISNI:0000 0001 2155 0800) 
11  Medical School National and Kapodistrian University of Athens, Laboratory of Biology, School of Medicine, Athens, Greece (GRID:grid.5216.0) (ISNI:0000 0001 2155 0800); University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
12  University of Oxford, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Medical School National and Kapodistrian University of Athens, Laboratory of Biology, School of Medicine, Athens, Greece (GRID:grid.5216.0) (ISNI:0000 0001 2155 0800) 
13  Biomedical Research Foundation Academy of Athens, Center of Clinical, Experimental Surgery & Translational Research, Athens, Greece (GRID:grid.417975.9) (ISNI:0000 0004 0620 8857); University of Crete, Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, Heraklion, Greece (GRID:grid.8127.c) (ISNI:0000 0004 0576 3437); Foundation for Research and Technology, Institute of Molecular Biology and Biotechnology, Heraklion, Greece (GRID:grid.4834.b) (ISNI:0000 0004 0635 685X); University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
Pages
4988
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3066599307
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.